Herndon Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$15K Hold
113
﹤0.01% 114
2017
Q1
$14K Hold
113
﹤0.01% 117
2016
Q4
$13K Sell
113
-4,366
-97% -$486K ﹤0.01% 119
2016
Q3
$468K Sell
4,479
-4,719
-51% -$511K 0.02% 52
2016
Q2
$907K Sell
9,198
-6,128
-40% -$634K 0.03% 60
2016
Q1
$1.53M Sell
15,326
-286
-2% -$29.4K 0.04% 69
2015
Q4
$1.87M Sell
15,612
-19
-0.1% -$2.2K 0.04% 61
2015
Q3
$1.69M Sell
15,631
-563
-3% -$69.9K 0.03% 72
2015
Q2
$1.87M Sell
16,194
-5,024
-24% -$574K 0.03% 80
2015
Q1
$2.44M Buy
21,218
+3,726
+21% +$445K 0.04% 77
2014
Q4
$1.96M Sell
17,492
-123
-0.7% -$13K 0.03% 86
2014
Q3
$1.67M Sell
17,615
-1,859
-10% -$168K 0.02% 98
2014
Q2
$1.67M Sell
19,474
-1,064
-5% -$80.9K 0.02% 105
2014
Q1
$1.43M Sell
20,538
-220
-1% -$17.4K 0.02% 104
2013
Q4
$1.75M Sell
20,758
-6,404
-24% -$507K 0.02% 107
2013
Q3
$2.09M Buy
27,162
+282
+1% +$19.8K 0.03% 102
2013
Q2
$1.57M Buy
+26,880
New +$1.62M 0.02% 110

Other funds holding CELG

Herndon Capital Management's CELG Position: Q2 2017 in Review

Herndon Capital Management held its Celgene Corp (CELG) position steady in Q2 2017 at 113 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #114.

Herndon Capital Management first reported a position in CELG in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.44M in Q1 2015. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

  • Herndon Capital Management held 113 shares of Celgene Corp worth $15K as of Q2 2017.
  • Herndon Capital Management left its Celgene Corp share count unchanged in Q2 2017.
  • Celgene Corp made up ﹤0.01% of Herndon Capital Management's portfolio in Q2 2017, its #114 holding.
  • Herndon Capital Management first reported a position in Celgene Corp in Q2 2013 and has held it in 17 quarters since.
  • Herndon Capital Management's Celgene Corp position peaked at $2.44M in Q1 2015.
  • 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Herndon Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.